PHARMA
Quarterly rpt on consolidated results for the financial period ended 30 Jun 2019
Amended Announcements
Please refer to the earlier announcement reference number: FRA-19082019-00040
| PHARMANIAGA BERHAD |
| Financial Year End | 31 Dec 2019 |
| Quarter | 2 Qtr |
| Quarterly report for the financial period ended | 30 Jun 2019 |
| The figures | have not been audited |
- Default Currency
- Other Currency
Currency: Malaysian Ringgit (MYR)
SUMMARY OF KEY FINANCIAL INFORMATION
|
INDIVIDUAL PERIOD
|
CUMULATIVE PERIOD
|
||||
CURRENT YEAR QUARTER
|
PRECEDING YEAR CORRESPONDING QUARTER |
CURRENT YEAR TO DATE
|
PRECEDING YEAR CORRESPONDING PERIOD |
||
|
30 Jun 2019
|
30 Jun 2018
|
30 Jun 2019
|
30 Jun 2018
|
||
|
$$'000
|
$$'000
|
$$'000
|
$$'000
|
||
| 1 | Revenue |
601,890
|
582,729
|
1,387,998
|
1,200,652
|
| 2 | Profit/(loss) before tax |
12,481
|
11,970
|
42,724
|
40,677
|
| 3 | Profit/(loss) for the period |
9,262
|
5,766
|
28,910
|
23,355
|
| 4 | Profit/(loss) attributable to ordinary equity holders of the parent |
9,281
|
5,394
|
28,898
|
22,980
|
| 5 | Basic earnings/(loss) per share (Subunit) |
3.56
|
2.08
|
11.09
|
8.84
|
| 6 | Proposed/Declared dividend per share (Subunit) |
2.50
|
4.00
|
8.50
|
9.00
|
AS AT END OF CURRENT QUARTER
|
AS AT PRECEDING FINANCIAL YEAR END
|
||||
| 7 |
Net assets per share attributable to ordinary equity holders of the parent ($$) |
1.9900
|
1.9600
|
||
Definition of Subunit:
In a currency system, there is usually a main unit (base) and
subunit that is a fraction amount of the main unit.
Example for the subunit as follows:
| Country | Base Unit | Subunit |
| Malaysia | Ringgit | Sen |
| United States | Dollar | Cent |
| United Kingdom | Pound | Pence |
Announcement Info
| Company Name | PHARMANIAGA BERHAD |
| Stock Name | PHARMA |
| Date Announced | 23 Aug 2019 |
| Category | Financial Results |
| Reference Number | FRA-23082019-00067 |